TGA Approval

SIMULECT basiliximab (rmc) 20mg powder for injection vial (440470)

ARTG ID

440470

ARTG Name

SIMULECT basiliximab (rmc) 20mg powder for injection vial

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

October 22, 2024

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/564cad3a2e212fdfae77ece23f74d236.pdf

Ingredient Name

Basiliximab

Empowering clinical research with data-driven insights and AI-powered tools.

SIMULECT basiliximab (rmc) 20mg powder for injection vial (440470) - TGA 批准文号 | MedPath